Logo image of SVRE

SAVERONE 2014 LTD -ADR (SVRE) Stock Fundamental Analysis

NASDAQ:SVRE - US80516T1051 - ADR

1.875 USD
+0.02 (+1.35%)
Last: 8/29/2025, 8:00:01 PM
1.93 USD
+0.05 (+2.93%)
After Hours: 8/29/2025, 8:00:01 PM
Fundamental Rating

2

Taking everything into account, SVRE scores 2 out of 10 in our fundamental rating. SVRE was compared to 125 industry peers in the Electronic Equipment, Instruments & Components industry. SVRE may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, SVRE is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year SVRE has reported negative net income.
In the past year SVRE has reported a negative cash flow from operations.
SVRE had negative earnings in each of the past 5 years.
SVRE had a negative operating cash flow in each of the past 5 years.
SVRE Yearly Net Income VS EBIT VS OCF VS FCFSVRE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 -10M -20M -30M

1.2 Ratios

With a Return On Assets value of -146.69%, SVRE is not doing good in the industry: 92.80% of the companies in the same industry are doing better.
SVRE has a Return On Equity of -328.67%. This is amonst the worse of the industry: SVRE underperforms 92.80% of its industry peers.
Industry RankSector Rank
ROA -146.69%
ROE -328.67%
ROIC N/A
ROA(3y)-114.85%
ROA(5y)-103.98%
ROE(3y)-247.57%
ROE(5y)-200.21%
ROIC(3y)N/A
ROIC(5y)N/A
SVRE Yearly ROA, ROE, ROICSVRE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 -1K -2K

1.3 Margins

SVRE has a better Gross Margin (36.48%) than 60.80% of its industry peers.
SVRE's Gross Margin has improved in the last couple of years.
SVRE does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 36.48%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.44%
GM growth 5Y8.11%
SVRE Yearly Profit, Operating, Gross MarginsSVRE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K -8K -10K

2

2. Health

2.1 Basic Checks

SVRE does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, SVRE has more shares outstanding
SVRE has more shares outstanding than it did 5 years ago.
SVRE has a better debt/assets ratio than last year.
SVRE Yearly Shares OutstandingSVRE Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M
SVRE Yearly Total Debt VS Total AssetsSVRE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

SVRE has an Altman-Z score of -13.08. This is a bad value and indicates that SVRE is not financially healthy and even has some risk of bankruptcy.
SVRE has a worse Altman-Z score (-13.08) than 92.00% of its industry peers.
A Debt/Equity ratio of 0.65 indicates that SVRE is somewhat dependend on debt financing.
SVRE has a worse Debt to Equity ratio (0.65) than 80.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF N/A
Altman-Z -13.08
ROIC/WACCN/A
WACC6.46%
SVRE Yearly LT Debt VS Equity VS FCFSVRE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M

2.3 Liquidity

A Current Ratio of 1.82 indicates that SVRE should not have too much problems paying its short term obligations.
SVRE has a worse Current ratio (1.82) than 64.80% of its industry peers.
SVRE has a Quick Ratio of 1.40. This is a normal value and indicates that SVRE is financially healthy and should not expect problems in meeting its short term obligations.
SVRE has a Quick ratio of 1.40. This is comparable to the rest of the industry: SVRE outperforms 40.80% of its industry peers.
Industry RankSector Rank
Current Ratio 1.82
Quick Ratio 1.4
SVRE Yearly Current Assets VS Current LiabilitesSVRE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 73.07% over the past year.
The Revenue for SVRE has decreased by -38.13% in the past year. This is quite bad
SVRE shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 81.69% yearly.
EPS 1Y (TTM)73.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%80.46%
Revenue 1Y (TTM)-38.12%
Revenue growth 3Y55.22%
Revenue growth 5Y81.69%
Sales Q2Q%-3.61%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
The Revenue is expected to grow by 194.03% on average over the next years. This is a very strong growth
EPS Next Y-10273.13%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year318.51%
Revenue Next 2Y194.03%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
SVRE Yearly Revenue VS EstimatesSVRE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 5M 10M 15M
SVRE Yearly EPS VS EstimatesSVRE Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 -1K -2K -3K -4K -5K

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SVRE. In the last year negative earnings were reported.
Also next year SVRE is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SVRE Price Earnings VS Forward Price EarningsSVRE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SVRE Per share dataSVRE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -500 -1K -1.5K

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

SVRE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

SAVERONE 2014 LTD -ADR

NASDAQ:SVRE (8/29/2025, 8:00:01 PM)

After market: 1.93 +0.05 (+2.93%)

1.875

+0.02 (+1.35%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)09-20 2022-09-20/bmo
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner Change-14.56%
Ins Owners0.15%
Ins Owner ChangeN/A
Market Cap2.14M
Analysts82.86
Price Target15.51 (727.2%)
Short Float %8.74%
Short Ratio0.04
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)19.39%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)45.79%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 4.24
P/FCF N/A
P/OCF N/A
P/B 0.67
P/tB 0.67
EV/EBITDA N/A
EPS(TTM)-16.1
EYN/A
EPS(NY)-1695.1
Fwd EYN/A
FCF(TTM)-9.06
FCFYN/A
OCF(TTM)-9.04
OCFYN/A
SpS0.44
BVpS2.79
TBVpS2.79
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -146.69%
ROE -328.67%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 36.48%
FCFM N/A
ROA(3y)-114.85%
ROA(5y)-103.98%
ROE(3y)-247.57%
ROE(5y)-200.21%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.44%
GM growth 5Y8.11%
F-Score4
Asset Turnover0.07
Health
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 18.9%
Cap/Sales 4.69%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.82
Quick Ratio 1.4
Altman-Z -13.08
F-Score4
WACC6.46%
ROIC/WACCN/A
Cap/Depr(3y)18.53%
Cap/Depr(5y)29.32%
Cap/Sales(3y)4.87%
Cap/Sales(5y)16.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)73.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%80.46%
EPS Next Y-10273.13%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-38.12%
Revenue growth 3Y55.22%
Revenue growth 5Y81.69%
Sales Q2Q%-3.61%
Revenue Next Year318.51%
Revenue Next 2Y194.03%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y2.84%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y1.89%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y1.75%
OCF growth 3YN/A
OCF growth 5YN/A